LB Pharmaceuticals Announces Pricing of its Upsized Initial Public Offering
NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) — LB Pharmaceuticals Inc (“LB Pharmaceuticals”) today announced the pricing of its upsized initial…
Pharmaceuticals, Biotechnology and Life Sciences
NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) — LB Pharmaceuticals Inc (“LB Pharmaceuticals”) today announced the pricing of its upsized initial…
WINNIPEG, Manitoba, Sept. 10, 2025 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech” or “Kane”) today announces that it…
Spectral Flow Cytometry Pioneer Unveils Innovations Accelerating Efficiency and DiscoveryFREMONT, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) — With cancer research…
– Second-generation constructs induce robust increases in fecal IgA, which was shown to be correlated with protection against infection in…
SAN DIEGO, Sept. 10, 2025 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on September 10, 2025,…
ROCKAWAY, N.J., Sept. 10, 2025 (GLOBE NEWSWIRE) — electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness…
BOSTON and SAN DIEGO, Sept. 09, 2025 (GLOBE NEWSWIRE) — Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a…
MELBOURNE, Australia and INDIANAPOLIS, Sept. 10, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces…
CHICAGO and FORT WORTH, Texas, Sept. 09, 2025 (GLOBE NEWSWIRE) — Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”),…
NASHVILLE, Tenn., Sept. 08, 2025 (GLOBE NEWSWIRE) — Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today…